Skip to main content

Table 3 Multivariate analysis for overall survival and progression free survival in patients with PTCL- NOS

From: Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy

  OS
P-value
HR (95% CI) PFS
P-value
HR (95% CI)
IPI     
   L, LI < 0.001 4.06 (95% CI 2.40-6.84) < 0.001 2.43 (95% CI 1.51-3.90)
   HI, H     
ALC     
   ≥ 1.0 × 109/l 0.002 2.24 (95% CI 1.33-3.78) 0.008 1.94 (95% CI 1.19-3.18)
   < 1.0 × 109/l     
  1. IPI, International Prognostic Index; L, low; LI, low-intermediate; HI, high-intermediate; H, high; ALC, absolute lymphocyte count; OS, overall survival; PFS, progression free survival.